Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Potential software issues on mammomat inspiration with system version vb30 and biopsy functionality. the system may freeze and the biopsy cannot be continued in the following situations: the compression force drops e.G. due to patient movement during the active targeting phase or during the targeting phase the inversion tool is used while the scout image is active. as a result of the system freeze the biopsy may have to be repeated.